Importance of murine study design for testing toxicity of retroviral vectors in support of phase I trials.
Will E; Bailey J; Schuesler T; Modlich U; Balcik B; Burzynski B; Witte D; Layh-Schmitt G; Rudolph C; Schlegelberger B; von Kalle C; Baum C; Sorrentino BP; Wagner LM; Kelly P; Reeves L; Williams DA; Molecular Therapy: The Journal Of The American Society Of Gene Therapy, 2007, vol. 15, issue 4, p 782, ISSN 15250016. ISBN 15250016.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef